NVCT

Nuvectis Pharma, Inc.

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Ken GriffinCitadel Advisors $-690.8K ExitQ1 2026 $691k -- $10.19
Jim SimonsRenaissance Technologies $-257.7K ExitQ4 2025 $258k -- $10.19
Ken GriffinCitadel Advisors $356.0K AddQ3 2025 $356k -- $10.19
Jim SimonsRenaissance Technologies $-63.6K TrimQ3 2025 $64k -- $10.19
Ken GriffinCitadel Advisors $-461.0K TrimQ2 2025 $461k -- $10.19
Jim SimonsRenaissance Technologies $-99.4K ExitQ4 2024 $99k -- $10.19